Literature DB >> 2252013

The who's and when's of therapy for Helicobacter pylori.

D Y Graham, G M Börsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2252013

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  10 in total

1.  In vitro and in vivo antibacterial activities of TAK-083, an agent for treatment of Helicobacter pylori infection.

Authors:  T Kanamaru; Y Nakano; Y Toyoda; K I Miyagawa; M Tada; T Kaisho; M Nakao
Journal:  Antimicrob Agents Chemother       Date:  2001-09       Impact factor: 5.191

Review 2.  A risk-benefit assessment of drugs used in the eradication of Helicobacter pylori infection.

Authors:  A Hackelsberger; P Malfertheiner
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

3.  Amoxicillin plus omeprazole versus triple therapy for eradication of Helicobacter pylori in duodenal ulcer disease: a prospective, randomized, and controlled study.

Authors:  J Labenz; E Gyenes; G H Rühl; G Börsch
Journal:  Gut       Date:  1993-09       Impact factor: 23.059

4.  Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands.

Authors:  E J van der Wouden; A A van Zwet; G D Vosmaer; J A Oom; A de Jong; J H Kleibeuker
Journal:  Emerg Infect Dis       Date:  1997 Jul-Sep       Impact factor: 6.883

5.  Detection of Helicobacter pylori in dental plaque by reverse transcription-polymerase chain reaction.

Authors:  A M Nguyen; L Engstrand; R M Genta; D Y Graham; F A el-Zaatari
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

6.  Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori.

Authors: 
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

Review 7.  Indications for treatment of Helicobacter pylori infection: a systematic overview.

Authors:  S J Veldhuyzen van Zanten; P M Sherman
Journal:  CMAJ       Date:  1994-01-15       Impact factor: 8.262

8.  Use of time-kill methodology to assess antimicrobial combinations against metronidazole-susceptible and metronidazole-resistant strains of Helicobacter pylori.

Authors:  P E Coudron; C W Stratton
Journal:  Antimicrob Agents Chemother       Date:  1995-12       Impact factor: 5.191

9.  Detection of the intragastric sites at which Helicobacter pylori evades treatment with amoxycillin and cimetidine.

Authors:  J C Atherton; A Cockayne; M Balsitis; G E Kirk; C J Hawkey; R C Spiller
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

10.  Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori.

Authors:  N Nagahara; Y Akiyama; M Nakao; M Tada; M Kitano; Y Ogawa
Journal:  Antimicrob Agents Chemother       Date:  1998-10       Impact factor: 5.191
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.